Market Tracker

10/21 6:05pm ET

SPDR® S&P Biotech ETF (XBI)

Data as of 3:59pm ET
 +1.71 / +1.08%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+0.29% 3 years+36.30%
3 months+14.50% 5 years+26.26%
1 year+30.37% Since inception+14.69%
Data through 10/21/2014

Quote Details

Previous close$158.94
Open day’s range158.80 – 161.19
Net asset value (NAV)158.92 (10/20/2014)
Daily volume353,343
Average volume (3 months)387,351
Data as of 3:59pm ET, 10/21/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+26.26%+21.83%
Expense Gross exp ratio0.35%0.42%
Risk 5 year sharpe ratio0.971.39
Net assets$1.2B$1.5B
Average market cap$2.0B$27.2B
Average P/E--29.1
Dividend / Share--0.20%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AGIO Agios Pharmaceuticals Inc1.85%
PTCT PTC Therapeutics Inc1.79%
AMAG AMAG Pharmaceuticals Inc1.64%
MACK Merrimack Pharmaceuticals Inc1.61%
VRTX Vertex Pharmaceuticals Inc1.61%
ACOR Acorda Therapeutics Inc1.48%
ALNY Alnylam Pharmaceuticals Inc1.43%
RGEN Repligen Corp1.42%
BMRN Biomarin Pharmaceutical Inc1.41%
MYGN Myriad Genetics Inc1.40%